Full Text Full Text (PDF) CME: Take the course for this article: AJP CME Course for March 2008: Augmentation of Behavior Therapy With D-Cycl... Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Wilhelm, S. Articles by Rauch, S. L. Search for Related Content PubMed Citation Articles by Wilhelm, S. Articles by Rauch, S. L. Obsessive-Compulsive Disorder Behavior Therapy Other Somatic Therapy Related Articles

Augmentation of Behavior Therapy With D-Cycloserine for Obsessive-Compulsive Disorder

OBJECTIVE: This study examined whether D-cycloserine, a partial agonist at the N-methyl-D-aspartate (NMDA) glutamatergic receptor, enhances the efficacy of behavior therapy for obsessive-compulsive disorder (OCD). METHOD: A randomized, double-blind, placebo-controlled trial investigating D-cycloserine versus placebo augmentation of behavior therapy was conducted in 23 OCD patients. Patients first underwent a diagnostic interview and pretreatment evaluation, followed by a psychoeducational/treatment planning session. Then they received 10 behavior therapy sessions. Treatment sessions were conducted twice per week. One hour before each of the behavior therapy sessions, the participants received either D-cycloserine, 100 mg, or a placebo. RESULTS: Relative to the placebo group, the D-cycloserine group’s OCD symptoms were significantly more improved at mid-treatment, and the D-cycloserine group’s depressive symptoms were significantly more improved at posttreatment. CONCLUSIONS: These data provide support for the use of D-cycloserine as an augmentation of behavior therapy for OCD and extend findings in animals and other human disorders suggesting that behavior therapy acts by way of long-term potentiation of glutamatergic pathways and that the effects of behavior therapy are potentiated by an NMDA agonist.

Related Articles:

Critical Parameters for D-Cycloserine Enhancement of Cognitive-Behaviorial Therapy for Obsessive-Compulsive Disorder

Barbara Olasov Rothbaum
Am J Psychiatry 2008 165: 293-296. [Full Text] [PDF]

This article has been cited by other articles:

				S. S. SHIM, M. D. HAMMONDS, and M. M. VRABEL D-Cycloserine Augmentation for Behavioral Therapy Am J Psychiatry, August 1, 2008; 165(8): 1050 - 1050. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us